Search for an orphan drug
Other search option(s)
Marketing authorization with orphan designation - USA
- Tradename: LEUKINE
- ATC code : L03AA09
- EU Number: -
- MA date : 29/03/2018
- MA holder: PARTNER THERAPEUTICS, INC.
LEUKINE is indicated to increase survival in adult and pediatric patients from birth to 17 years of age acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome [H-ARS]
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.